对非小细胞肺癌的辅助疗法的最新进展
Mi-Hyun Kim1,2, Soo Han Kim1,2, Min Ki Lee1,2
1Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea.
Tuberculosis and respiratory diseases
|November 15, 2023
概括
辅助向疗法和免疫疗法在早期非小细胞肺癌 (NSCLC) 中表现有前途. 本综述涵盖了NSCLC辅助治疗的最新进展和正在进行的试验,并解决了关于最佳策略的剩余问题.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 向治疗和免疫疗法已经改变了高级非小细胞肺癌 (NSCLC) 治疗.
- 这些创新疗法正在越来越多地被探索在早期NSCLC的辅助设置.
- 已批准的辅助治疗包括对EGFR突变NSCLC的奥西默蒂尼布和对可切除NSCLC的阿特佐利祖马布/佩姆布罗利祖马布.
研究的目的:
- 审查助剂向疗法和早期非小细胞肺癌 (NSCLC) 免疫疗法的最新进展.
- 总结正在进行的临床试验,研究这些治疗方式在辅助环境中.
- 解决关于早期NSCLC最佳辅助治疗策略的尚未解决的问题.
主要方法:
- 对早期NSCLC的辅助向治疗和免疫治疗现有研究的文献综述.
- 专注于最近的临床试验数据和已批准的辅助治疗.
- 综合当前的证据和确定正在进行的研究.
主要成果:
- 一些向疗法和免疫疗法正在研究用于早期NSCLC的辅助设置.
- 奥西默蒂尼布,阿特佐利祖马布和潘布罗利祖马布是已批准或正在研究的辅助剂选择之一.
- 许多临床试验正在进行中,以进一步评估疗效和最佳使用.
结论:
- 辅助向疗法和免疫疗法是早期NSCLC管理的快速发展领域.
- 目前正在进行的研究旨在确定这些治疗方法的最佳策略和患者群体.
- 进一步调查至关重要,以回答剩余的问题,并完善NSCLC的辅助治疗方案.
更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.0K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:30Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376